The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations.

Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters.

Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning.

Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care.

Transitions in relabeling personalized medicine as precision medicine, precision health, or wellness genomics reflect shifting the locus of responsibility for health from individuals to clinicians and in shifting focus from genetic risk to genetic enhancement.

Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.

Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients.

African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.

IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations.

Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies.